caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1790702397

Christina MyintM.D.

PRACTICETRINA BIVENS MD PASee all providers at this practice →
Internal MedicineDallas, TXI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
922
Unique beneficiaries
—
Total services
1,437
Distinct HCPCS
8
Medicare payment
$91K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 6,183 Internal Medicine providers in TX — above median (cohort median 673).
REFERRAL NETWORK

Where Christina Myint's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Clinical Pathology Laboratories, Inc.
Clinical Laboratory · Austin, TX
98196
Marilyn Horton
Internal Medicine · Dallas, TX
5993
Swdic Imaging Center Partnership, Llp
Independent Diagnostic Testing Facility (IDTF) · Dallas, TX
3850
TEXAS HEALTH PRESBYTERIAN HOSPITAL DALLAS3555
Laboratory Corporation Of America
Clinical Laboratory · Dallas, TX
1536
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
5,079
Beneficiaries
—
Total drug cost
$230K
Distinct drugs
93
Brand share
16.2%
Top prescribed drugs
Rosuvastatin Calcium409 claims
Atorvastatin Calcium338 claims
Losartan Potassium288 claims
Amlodipine Besylate246 claims
Levothyroxine Sodium195 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
QUALITY · MIPS · 2024
Final MIPS score
92.5
Quality
85.6
Cost
0.0
Improvement activities
40.0
Promoting interop.
99.0
Payment adjustment
0.74%
APM Entity